Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

The Receptor for Advanced Glycation End Products (RAGE) is an important cell surface receptor, which belongs to the IgG super family and is now considered as a pattern recognition receptor. Because of its relevance in many human clinical settings, it is now pursued as a very attractive therapeutic target. However, particular features of this receptor such as a wide repertoire of ligands with different binding domains, the existence of many RAGE variants as well as the presence of cytoplasmatic adaptors leading a diverse signaling, are important limitations in the search for successful pharmacological approaches to inhibit RAGE signaling. Therefore, the present review aimed to display the most promising approaches to inhibit RAGE signaling, and provide an up to date review of progress in this area.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450119666180820105956
2019-03-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450119666180820105956
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test